Bruker Corp. Aktie
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | -0,69 % | -13,59 % | -26,82 % | -36,01 % | -25,15 % | - | - |
| Healthequity Inc. | 0,00 % | -7,52 % | -15,75 % | -42,52 % | -21,15 % | -1,60 % | -12,14 % |
| Omnicell Inc. | 0,66 % | -6,75 % | -29,95 % | -18,28 % | -21,65 % | -40,39 % | -72,11 % |
| Myriad Genetics | 0,00 % | -12,62 % | -25,94 % | -73,29 % | -29,43 % | -78,95 % | -85,07 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




